TOP RATED Abstracts


The 20 highest-scoring scientific abstracts (as rated by the ECCVID abstract reviewers) are specially highlighted with the awarding of the ‘Top-Rated Abstract’ title. They are listed below.

No Abstract title Submitter lastname Submitter firstname Presenting author
3 Evaluating ten commercially-available SARS-CoV-2 rapid serological tests using the STARD (Standards for Reporting of Diagnostic Accuracy Studies) method Naas Thierry DORTET Laurent
68 Cell-based culture of SARS-CoV-2 informs infectivity and safe de-isolation assessments during COVID-19 Basile Kerri BASILE Kerri
80 Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome de Vries Rory DE VRIES Rory d.
90 The Influence of Population Mobility on SARS-CoV-2 Transmission in Latin America Gómez Ochoa Sergio Alejandro GOMEZ-OCHOA Sergio alejandro
142 Whole-genome sequencing confirms nosocomial SARS-CoV-2 transmission between healthcare workers and patients Lucey Mary LUCEY Mary
144 Containment of COVID-19 in a complex multi-institutional healthcare system over a six-month period: the role of patient segregation, risk-stratified testing, centralised surveillance and universal masking Sng Edwin DE VRIES Rory d.
155 Systematic screening on admission for SARS-CoV-2 to detect asymptomatic infections Stadler Rahel STADLER Rahel
172 Comparison of a Host Response Classifier to IL-6 and Other Clinical Markers for Predicting Severe Respiratory Failure in COVID-19 Cheng Henry SWEENEY Tim
212 Combined serological and molecular SARS-CoV-2 screening in healthcare workers: a targeted population analysis from the a COVID-19 reference clinical center Tartaglione Livia DI RUSCIO Federica
300 SARS-CoV-2 genomic and quasispecies analyses in cancer patients reveal relaxed intrahost virus evolution Soares Marcelo SOARES Marcelo
338 Genomic epidemiology of SARS-CoV-2 in Spain Gonzalez-Candelas Fernando GONZÁLEZ-CANDELAS Fernando
368 SARS-CoV-2 phylodynamics differentiates the effectiveness of non-pharmaceutical interventions Rasigade Jean-Philippe RASIGADE Jean-philippe
384 Does adaptive evolution of spike protein of novel Severe Acute Respiratory Syndrome Coronavirus –2 (SARS-CoV-2) contributes towards disease severity? Ratho Radha Kanta RATHO Radha kanta
449 Viral epidemiology and SARS-CoV-2 coinfections with other respiratory viruses during the first COVID-19 wave in Paris, France Visseaux Benoit LE HINGRAT Quentin
480 COVID-19 Genome Analysis Pipeline (COVGAP): tracking antiviral resistance of SARS-CoV-2 Mari Alfredo MARI Alfredo
504 Subgenomic RNA as a surrogate marker for active SARS-CoV-2 replication in health care workers for work reincorporation Santos Bravo Marta SANTOS BRAVO Marta
520 Development and validation of phenotypes for COVID-19 patients with prognostic implications (FEN-COVID project) Gutiérrez-Gutiérrez Belén GUTIÉRREZ-GUTIÉRREZ Belén
553 Systematic review and patient-level meta-analysis of SARS-CoV-2 viral dynamics to model response to antiviral therapies Standing Joe STANDING Joe
563 COVID-19 infection dynamics in care homes in the East of England: a retrospective genomic epidemiology study Hamilton William HAMILTON William
674 First nationwide, cross-specialty surveillance study of acute complications of COVID-19 in the nervous system Thomas Rhys RHYS Thomas